AAAAAA

   
Results: 1-7 |
Results: 7
TANDEM-IN-TIME MASS-SPECTROMETRY AS A QUANTITATIVE BIOANALYTICAL TOOL
Authors: ROSSI DT HOFFMAN KL JANICZEKDOLPHIN N BOCKBRADER H PARKER TD
Citation: Dt. Rossi et al., TANDEM-IN-TIME MASS-SPECTROMETRY AS A QUANTITATIVE BIOANALYTICAL TOOL, Analytical chemistry, 69(22), 1997, pp. 4519-4523
SAFETY AND TOLERABILITY OF CI-979 IN PATIENTS WITH ALZHEIMERS-DISEASE
Authors: SRAMEK JJ SEDMAN AJ REECE PA HOURANI J BOCKBRADER H CUTLER NR
Citation: Jj. Sramek et al., SAFETY AND TOLERABILITY OF CI-979 IN PATIENTS WITH ALZHEIMERS-DISEASE, Life sciences, 57(5), 1995, pp. 503-510
PRECLINICAL AND PHASE-1 CLINICAL CHARACTERIZATION OF CI-979 RU35926, A NOVEL MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE/
Authors: SEDMAN AJ BOCKBRADER H SCHWARZ RD
Citation: Aj. Sedman et al., PRECLINICAL AND PHASE-1 CLINICAL CHARACTERIZATION OF CI-979 RU35926, A NOVEL MUSCARINIC AGONIST FOR THE TREATMENT OF ALZHEIMERS-DISEASE/, Life sciences, 56(11-12), 1995, pp. 877-882
PHARMACOKINETICS OF GABAPENTIN IN SUBJECTS WITH VARIOUS DEGREES OF RENAL-FUNCTION
Authors: BLUM RA COMSTOCK TJ SICA DA SCHULTZ RW KELLER E REETZE P BOCKBRADER H TUERCK D BUSCH JA REECE PA SEDMAN AJ
Citation: Ra. Blum et al., PHARMACOKINETICS OF GABAPENTIN IN SUBJECTS WITH VARIOUS DEGREES OF RENAL-FUNCTION, Clinical pharmacology and therapeutics, 56(2), 1994, pp. 154-159
SAFETY AND TOLERANCE OF THE MUSCARINIC AGONIST CI-979
Authors: CUTLER NR SRAMEK JJ SEIFERT RD HOURANI J REECE PA BOCKBRADER H SEDMAN AJ
Citation: Nr. Cutler et al., SAFETY AND TOLERANCE OF THE MUSCARINIC AGONIST CI-979, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 174-174
MAXIMALLY TOLERATED DOSE OF THE MUSCARINIC AGONIST CI-979 IN ALZHEIMERS-DISEASE (AD)
Authors: CUTLER NR SRAMEK JJ SEIFERT RD HOURANI J REECE PA BOCKBRADER H SEDMAN AJ WARDLE TS
Citation: Nr. Cutler et al., MAXIMALLY TOLERATED DOSE OF THE MUSCARINIC AGONIST CI-979 IN ALZHEIMERS-DISEASE (AD), Biological psychiatry, 35(9), 1994, pp. 628-628
IDENTIFICATION OF A PYRIDINIUM METABOLITE IN HUMAN URINE FOLLOWING A SINGLE ORAL DOSE OF OXY]ETHYL]-1,2,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLICACID MONOHYDROCHLORIDE, A GAMMA-AMINOBUTYRIC-ACID UPTAKE INHIBITOR
Authors: RADULOVIC L WOOLF T BJORGE S TAYLOR C REILY M BOCKBRADER H CHANG T
Citation: L. Radulovic et al., IDENTIFICATION OF A PYRIDINIUM METABOLITE IN HUMAN URINE FOLLOWING A SINGLE ORAL DOSE OF OXY]ETHYL]-1,2,5,6-TETRAHYDRO-3-PYRIDINECARBOXYLICACID MONOHYDROCHLORIDE, A GAMMA-AMINOBUTYRIC-ACID UPTAKE INHIBITOR, Chemical research in toxicology, 6(3), 1993, pp. 341-344
Risultati: 1-7 |